Effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy for glaucoma

Japanese Journal of Ophthalmology

Volumn 54, Issue 5, 2010, Pages 407-413

  Cho, Sung Woo ^a   Kim, Joon Mo ^a   Park, Ki Ho ^b   Choi, Chul Young ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

brimonidine; fixed combination; glaucoma; pupil; timolol

Indexed keywords

BRIMONIDINE PLUS TIMOLOL;

ADULT; ALLERGIC CONJUNCTIVITIS; ANTERIOR EYE SEGMENT; ARTICLE; BURNING SENSATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG THERAPY; DRUG WITHDRAWAL; FEMALE; FIXED COMBINATION THERAPY; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MIOSIS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; SOMNOLENCE; TREATMENT RESPONSE;

ANTIHYPERTENSIVE AGENTS; CIRCADIAN RHYTHM; DRUG COMBINATIONS; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PUPIL; QUINOXALINES; TIMOLOL; TONOMETRY, OCULAR; TREATMENT OUTCOME;

EID: 78649278930     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-010-0855-4     Document Type: Article

References (29)

1. A. Heijl M.C. Leske B. Bengtsson L. Hyman B. Bengtsson Hussein M.s Early Manifest Glaucoma Trial Group 2002 Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial Arch Ophthalmol 120 1268 1279 12365904
2. M.A. Kass D.K. Heuer E.J. Higginbotham, et al. 2002 The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma Arch Ophthalmol 120 701 713 12049574
3. A.M. Fremont P.P. Lee C.M. Mangione, et al. 2003 Patterns of care for open-angle glaucoma in managed care Arch Ophthalmol 121 777 783 10.1001/archopht.121.6.777 12796247
4. S.M. Drance 1960 The significance of the diurnal tension variations in normal and glaucomatous eyes Arch Ophthalmol 64 494 501 1:STN:280: DyaF3c%2Fktlyksw%3D%3D 13724271
5. I. Tajunisah S.C. Reddy J. Fathilah 2007 Diurnal variation of intraocular pressure in suspected glaucoma patients and their outcome Graefes Arch Clin Exp Ophthalmol 245 1851 1857 1:STN:280:DC%2BD2snotlOruw%3D%3D 10.1007/s00417-007- 0681-7 17901971
6. F.J. Goni 2005 12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertension Eur J Ophthalmol 15 581 590 1:STN:280:DC%2BD2MvpsVWnsg%3D%3D 16167288
7. M.B. Sherwood E.R. Craven C. Chou, et al. 2006 Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial Arch Ophthalmol 124 1230 1238 1:CAS:528:DC%2BD28XhtVGju73M 10.1001/archopht.124.9.1230 16966616
8. A. Iwase Y. Suzuki M. Araie, et al. 2004 Tajimi Study Group, Japan Glaucoma Society The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 111 1641 1648
9. The Advanced Glaucoma Intervention Study 2000 7. The relationship between control of intraocular pressure and visual field deterioration Am J Ophthalmol 130 429 440 10.1016/S0002-9394(00)00538-9
10. N. Koseki M. Araie S. Shirato S. Yamamoto 1997 Effect of trabeculectomy on visual field performance in central 30 degrees field in progressive normal-tension glaucoma Ophthalmology 104 197 201 1:STN:280:DyaK2s3gsFWitw%3D%3D 9052622
11. S. Abedin R.J. Simmons W.M. Grant 1982 Progressive low-tension glaucoma: treatment to stop glaucomatous cupping and field loss when these progress despite normal intraocular pressure Ophthalmology 89 1 6 1:STN:280: DyaL387ntlyisw%3D%3D 7070766
12. A.J. Sit 2009 Continuous monitoring of intraocular pressure: rationale and progress toward a clinical device J Glaucoma 18 272 279 10.1097/IJG. 0b013e3181862490 19365190
13. E.R. Craven T.R. Walters R. Williams C. Chou J.K. Cheetham R. Schiffman Combigan Study Group 2005 Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension J Ocul Pharmacol Ther 21 337 348 1:CAS:528: DC%2BD2MXovVOjtr4%3D 10.1089/jop.2005.21.337 16117698
14. S. Ishibashi N. Hirose A. Tawara T. Kubota 2006 Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma J Glaucoma 15 354 357 10.1097/01.ijg.0000212264.96864.3e 16988595
15. D.E. Potter C.E. Crosson A.R. Heath M.J. Ogidigben 1990 Review: alpha 2 and DA2 agonists as antiglaucoma agents: comparative pharmacology and clinical potential J Ocul Pharmacol 6 251 257 1:CAS:528:DyaK3MXhtlGgu7o%3D 10.1089/jop.1990.6.251 1981221
16. C.B. Toris M.L. Gleason C.B. Camras M.E. Yablonski 1995 Effects of brimonidine on aqueous humor dynamics in human eyes Arch Ophthalmol 113 1514 1517 1:CAS:528:DyaK28XmslOkuw%3D%3D 7487618
17. L. Wayman L.I. Larsson T. Maus A. Alm R. Brubaker 1997 Comparison of dorzolamide and timolol as suppressors of aqueous humor flow in humans Arch Ophthalmol 115 1368 1371 1:CAS:528:DyaK2sXns1ygsL0%3D 9366665
18. A.M. Bhorade 2009 The monocular trial controversy: a critical review Curr Opin Ophthalmol 20 104 109 10.1097/ICU.0b013e3283249c67 19248313
19. S.M. Drance 1980 The uniocular therapeutic trial in management of elevated IOP Surv Ophthalmol 25 203 205 1:STN:280:DyaL3M7is1OntQ%3D%3D 10.1016/0039-6257(80)90099-5 7466599
20. T.J. Zimmerman H.E. Kaufman 1977 Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma Arch Ophthalmol 95 601 604 1:CAS:528:DyaE2sXkslymt78%3D 322648
21. J. Piltz R. Gross D.H. Shin, et al. 2000 Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the Ocular Hypertension Treatment Study Am J Ophthalmol 130 441 453 1:CAS:528: DC%2BD3cXnt1ShsrY%3D 10.1016/S0002-9394(00)00527-4 11024416
22. Kim MS, Kim JM, Park KH, Choi CY. Asymmetry of diurnal intraocular pressure fluctuation between right and left eyes. Acta Ophthalmol [Epub ahead of print Oct 23 2009].
23. J.E. McDonald II A.M. El-Moatassem Kotb B.B. Decker 2001 Effect of brimonidine tartrate ophthalmic solution 0.2% on pupil size in normal eyes under different luminance conditions J Cataract Refract Surg 27 560 564 10.1016/S0886-3350(01)00769-6 11311624
24. D.A. Wilkie C.A. Latimer 1991 Effects of topical administration of timolol maleate on intraocular pressure and pupil size in cats Am J Vet Res 52 436 440 1:CAS:528:DyaK3MXit1Wgtrw%3D 2035918
25. D.A. Wilkie C.A. Latimer 1991 Effects of topical administration of timolol maleate on intraocular pressure and pupil size in dogs Am J Vet Res 52 432 435 1:CAS:528:DyaK3MXisVSmtrs%3D 2035917
26. W.P. Boger III C.A. Puliafito R.F. Steinert D.P. Langston 1978 Long-term experience with timolol ophthalmic solution in patients with openangle glaucoma Ophthalmology 85 259 267 351504
27. J.E. Thordsen K.S. Bower B.B. Warren R. Stutzman 2004 Miotic effect of brimonidine tartrate 0.15% ophthalmic solution in normal eyes J Cataract Refract Surg 30 1702 1706 10.1016/j.jcrs.2003.12.037 15313293
28. S.M. Brown A.M. Khanani D.L. McCartney 2004 The effect of daily use of brimonidine tartrate on the dark-adapted pupil diameter Am J Ophthalmol 138 149 151 1:CAS:528:DC%2BD2cXlsVWhtrs%3D 10.1016/j.ajo.2004.02.017 15234301
29. M.O. Gordon M.A. Kass Ocular Hypertension Treatment Study Group 1999 The Ocular Hypertension Treatment Study: design and baseline description of the participants Arch Ophthalmol 117 573 583 1:STN:280:DyaK1M3ls1yrtw%3D%3D 10326953